Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 1
1992 1
1993 3
1994 2
1995 1
1996 1
1997 1
1998 2
1999 6
2000 5
2001 3
2003 3
2004 4
2005 11
2006 4
2007 2
2008 7
2010 2
2011 3
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 10951729

65 results
Results by year
Filters applied: . Clear all
Page 1
Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.
Wright JM. Wright JM. CMAJ. 2000 Aug 8;163(3):293-6. CMAJ. 2000. PMID: 10951729 Free PMC article. Review.
Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diuretics.
Wright JM. Wright JM. CMAJ. 2000 Jul 11;163(1):57-60. CMAJ. 2000. PMID: 10920733 Free PMC article. Review.
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program. Khan NA, et al. Can J Cardiol. 2004 Jan;20(1):41-54. Can J Cardiol. 2004. PMID: 14968142
Angiotensin-converting enzyme inhibitors in the treatment of hypertension.
Mancia G. Mancia G. J Cardiovasc Pharmacol. 1991;18 Suppl 7:S1-3. J Cardiovasc Pharmacol. 1991. PMID: 1725194 Review.
Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers.
Wright JM. Wright JM. CMAJ. 2000 Jul 25;163(2):188-92. CMAJ. 2000. PMID: 10934984 Free PMC article. Review.
Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE, Julius S. Kjeldsen SE, et al. Am Heart J. 2004 Nov;148(5):747-54. doi: 10.1016/j.ahj.2004.04.037. Am Heart J. 2004. PMID: 15523303 Review.
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. Adigun AQ, et al. J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538. J Hum Hypertens. 2003. PMID: 12714973 Free article.
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD; Canadian Hypertension Education Program. Khan NA, et al. Can J Cardiol. 2005 Jun;21(8):657-72. Can J Cardiol. 2005. PMID: 16003449
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
McAlister FA, Levine M, Zarnke KB, Campbell N, Lewanczuk R, Leenen F, Rabkin S, Wright JM, Stone J, Feldman RD, Lebel M, Honos G, Fodor G, Burgess E, Tobe S, Hamet P, Herman R, Irvine J, Culleton B, Petrella R, Touyz R; Canadian Hypertension Recommendations Working Group. McAlister FA, et al. Can J Cardiol. 2001 May;17(5):543-59. Can J Cardiol. 2001. PMID: 11381277
[Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
Modesti PA, Vanni S, Gensini GF. Modesti PA, et al. Ital Heart J Suppl. 2003 Aug;4(8):623-34. Ital Heart J Suppl. 2003. PMID: 14655458 Review. Italian.
65 results
Jump to page
Feedback